共 50 条
- [41] Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (02): : 239 - 243
- [47] Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (09): : 2378 - 2385